These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 601748)

  • 21. Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: implications for the design of novel heparin mimics.
    Monien BH; Cheang KI; Desai UR
    J Med Chem; 2005 Aug; 48(16):5360-8. PubMed ID: 16078853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of thrombin to antithrombin III.
    Abildgaard U
    Scand J Clin Lab Invest; 1969 Aug; 24(1):23-7. PubMed ID: 5374920
    [No Abstract]   [Full Text] [Related]  

  • 23. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of heparin with thrombin and antithrombin III.
    Feinman RD; Li EH
    Fed Proc; 1977 Jan; 36(1):51-5. PubMed ID: 830556
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-sensitive and nonsensitive forms of thrombin.
    Machovich R
    Biochim Biophys Acta; 1975 Jul; 400(1):62-8. PubMed ID: 1170899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.
    Griffith MJ
    J Biol Chem; 1982 Jul; 257(13):7360-5. PubMed ID: 7085630
    [No Abstract]   [Full Text] [Related]  

  • 29. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of thrombin and antithrombin. Reaction observed by intrinsic fluorescence measurements.
    Wong RF; Windwer SR; Feinman RD
    Biochemistry; 1983 Aug; 22(17):3994-9. PubMed ID: 6615813
    [No Abstract]   [Full Text] [Related]  

  • 31. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives.
    Komatsu Y; Hayashi H
    Biol Pharm Bull; 2000 Apr; 23(4):502-5. PubMed ID: 10784436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
    Borsodi A; Machovich R
    Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the binding of heparin to prothrombin and thrombin and the effect of heparin-binding on thrombin activity.
    Nordenman B; Björk I
    Thromb Res; 1978 May; 12(5):755-65. PubMed ID: 675585
    [No Abstract]   [Full Text] [Related]  

  • 37. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity.
    Gans H; Boulton A
    Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
    Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
    Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.